Improved Testing for Fever After Tropical Travel

Rapid Molecular Diagnosis and Detection of Emerging Infectious Diseases in Patients With Tropical Fever (Tropifever)

Recruiting N/A Interventional Study
Infectious Diseases in Febrile Patients Returning From Tropical Countries
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 99
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
564 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Who this trial is looking for

This trial is looking for adults with a fever who have recently returned from tropical countries. Participants will undergo additional testing to help improve diagnosis and treatment of potential infections.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am an adult aged 18 or older.
  • I have a fever above 38°C.
  • I returned from a tropical country within the last 28 days.
  • I do not have sepsis.

You may not be able to join if

  • I need to be hospitalized.
  • I cannot give consent due to unconsciousness or language barriers.
  • I am under legal protection.
  • I refuse to participate.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Travellers returning from tropical countries often present to emergency departments with acute fever. While systematic screening for malaria is well established in clinical practice in France, further diagnostic testing for infectious diseases is less codified. In addition, the clinical presentation of many tropical and emerging infectious diseases is often similar, making a positive diagnosis in …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adult (age ≥ 18 years old) * Fever (tympanic temperature above 38°c measured in the emergency department) * Within 28 days of returning from tropical countries (Sub-Saharan Africa, South and Southeast Asia, Central and South America) * No sepsis (qSOFA \< 2) Exclusion Criteri…
Contacts

Nathan PEIFFER-SMADJA, MD, PhD

01 40 25 73 11

nathan.peiffer-smadja@aphp.fr

CONTACT